eISSN: 2081-2841
ISSN: 1689-832X
Journal of Contemporary Brachytherapy
Current Issue Archive Supplements Articles in Press Journal Information Aims and Scope Editorial Office Editorial Board Register as Author Register as Reviewer Instructions for Authors Abstracting and indexing Subscription Advertising Information Links
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
Search
3/2023
vol. 15
 
Share:
Send email
Share:
abstract:
Case report

A case of dermatofibrosarcoma protuberans of the scalp treated with surface mould brachytherapy

Raj Hans
1
,
Sankalp Singh
2
,
Prince Arvind
2
,
Arti Sarin
2
,
Manoj K. Semwal
2
,
Pankaj Vats
2

  1. Command Hospital (Southern Command), Pune, India
  2. Army Hospital (Research & Referral), Delhi, India
J Contemp Brachytherapy 2023; 15, 3: 224–228
DOI: https://doi.org/10.5114/jcb.2023.127807
Online publish date: 2023/05/31
View full text Get citation
 
Dermatofibrosarcoma protuberans (DFSP) is a locally aggressive soft tissue tumor with a high propensity of local recurrence after surgery. Radiotherapy as an adjuvant therapy has been shown to reduce recurrent rates of this disease. Surface mould brachytherapy is an effective and safe modality for the delivery of radiotherapy in soft tissue tumors, though its utilization and popularity have decreased in recent years. Here, we presented a case of a recurrent DFSP of the scalp who was treated with surgery followed by adjuvant surface mould brachytherapy to avoid dose inhomogeneity likely to occur in this anatomic region with external beam radiotherapy in the absence of intensity-modulated radiotherapy. The treatment was delivered successfully with minimal adverse reactions, and the patient is disease-free at 18 months post-treatment with no treatment toxicity.
keywords:

dermatofibrosarcoma protuberans, surface mould brachytherapy, radiotherapy, scalp

  
Termedia
About us Contact
Copyright notice Privacy policy Advertising policy Contact us
Quick links
Journals Books eBooks Events
© 2024 Termedia Sp. z o.o.
Developed by Bentus.